小肠神经内分泌肿瘤影像学作用的演变:一项回顾性观察研究中影像学估计影响与无病生存分析
该回顾性观察研究分析了1996至2016年在本机构病理确诊的178例小肠神经内分泌肿瘤(SBNEN),比较连续5年间的诊断方式变化及CT小肠造影(CTE)对诊断和无病生存率的影响。结果显示SBNEN发病率增加12倍,CTE检出小肠肿块和提示SBNEN的比率显著高于腹部CT,且CTE首先发现肿瘤者无病生存率更高、局部和肝转移发生率更低。
要点
- CTE检出小肠肿块及提示SBNEN的比率分别为95%(52/55)和91%(50/55),均显著高于腹部CT的45%(37/85)和35%(29/85)(p<0.0001)。
- 由CTE而非其他CT/MR检查首先发现肿瘤者,无病生存率更高,局部和肝转移发生率更低(p分别为0.0034、0.0475、0.0032)。
- SBNEN复发率随肿瘤增大而升高(p=0.012),内镜诊断的肿瘤中0.6±0.3 cm者复发18%,3.7±1.0 cm者复发75%。
关键影像表现/征象
- CTE检出小肠肿块比率为95%(52/55),腹部CT为45%(37/85)。
- CTE提示SBNEN存在的比率为91%(50/55),腹部CT为35%(29/85)。
诊断标准与关键数值
- CTE检出小肠肿块及提示SBNEN的比率显著高于腹部CT(p<0.0001),CTE分别为95%(52/55)和91%(50/55),腹部CT分别为45%(37/85)和35%(29/85)。
临床应用与阅片要点
- 由CTE而非其他CT/MR检查首先发现肿瘤者,无病生存率更高,局部和肝转移发生率更低(p分别为0.0034、0.0475、0.0032)。
- 内镜诊断的SBNEN中,0.6±0.3 cm者复发18%,3.7±1.0 cm者复发75%,复发率随肿瘤大小增加(p=0.012)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine how small bowel neuroendocrine neoplasms (SBNEN's) are diagnosed and examine the effect of CT enterography (CTE) on diagnosis and rates of disease-free survival.
METHODS: Histopathologically-confirmed SBNEN's diagnosed at our institution between 1996 and 2016 were identified. Clinical presentation, radiology, endoscopy, surgery, and pathology reports were reviewed and compared between consecutive 5-year periods.
RESULTS: Of the 178 SBNEN initially diagnosed at our institution, the incidence increased 12-fold from 9 (during 1996-2000) to 114 (during 2011-2016). Comparing the first 5 to the last 5 years, GI bleeding and abdominal pain increased significantly as indications (with both increasing from 0 to > 25%, p ≤ 0.023). Initial diagnosis by radiology increased 2-fold [from 33% (n = 3) to 66% (n = 75); p = 0.263]. Detection of a small bowel mass and the suggestion that SBNEN was present varied significantly between imaging modalities (p < 0.0001; CTE - 95% (52/55) and 91% (50/55) vs. abdominal CT 45% (37/85) and 35% (29/85), respectively). Recurrence rates increased with SBNEN size (p = 0.012; e.g., of SBNEN diagnosed by endoscopy, 18% of SBNEN measuring 0.6 ± 0.3 cm recurred vs. 75% measuring 3.7 ± 1.0 cm). Rates of disease-free survival, and the incidence of local and liver metastases were decreased when tumors were first identified by CTE rather than other CT/MR imaging modalities (p = 0.0034, 0.0475, and 0.0032, respectively).
CONCLUSION: There has been a dramatic increase in SBNENs detected by CTE and endoscopy over the last 20 years. SBNEN's detected by CTE and small tumors detected at endoscopy have longer disease-free survival after surgical resection.
引用
- Kim S, Marcus R, Wells ML, et al. The evolving role of imaging for small bowel neuroendocrine neoplasms: estimated impact of imaging and disease-free survival in a retrospective observational study. Abdom Radiol (NY). 2020. PMID: 31980866. doi:10.1007/s00261-020-02410-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。